技术和创新使影响因素变得多余——更好的替代品正在蓬勃发展

IF 0.6 Q4 ONCOLOGY South Asian Journal of Cancer Pub Date : 2023-04-10 DOI:10.1055/s-0043-1767699
Purvish M. Parikh, A. Vora
{"title":"技术和创新使影响因素变得多余——更好的替代品正在蓬勃发展","authors":"Purvish M. Parikh, A. Vora","doi":"10.1055/s-0043-1767699","DOIUrl":null,"url":null,"abstract":"Three recent publications have let the cat out of the bag. They are “Stop Congratulating Colleagues for Publishing in High Impact-Factor Journals,” “Who are the real parasite publishers and journals? What prevents all medical data from being open access in real time?” and “Against Parasite Publishers: Making Journals Free.”1–3 For long impact factor (IF) has ruled the academic publishing world. It has expanded its sphere of influence on career progress, appointments in academic institutions, promotion reviews, and grant applications. IF is popular since 1975 and is based on the number of citations that the journal received in the previous 2 years. For instance, if our article is published in the year 2022, the IF that the journal in which our article is published will be decided on the citations received by the journal in the years 2020 and 2021. Authors are cognizant of the significance of IF because journals with higher IF are considered as respectable, their review process is supposed to be selective, there is greater scrutiny of articles submitted, and if published, the authors are considered worthy by their peers. Publications in journals with high IF also cascade into wider publicity through reporting by science journals and social media. They also have a higher chance of being included in reports on new publications. As the definition suggests, there is also a higher chance of being cited by other scientists working in the field. However, IF has a very important flaw. All the metrics are related to the journal. There is no evaluation of the individual publication or the author who has done the research work. Therefore, having a publication in a high IF journal does not guarantee that your work will be cited. In fact, more than two-thirds of publications in such journals have fewer citations than the IF of the journal.4 By experience, we have found that using the right keywords does wonders to online access. When the research work is great, those interested in the subject can easily find it on the net. Searchable databases such as Scopus, Google Scholar, and Web of Science make this possible. There are also niche areas in science andmedicine, where journals with high IF simply do not exist. The research communities in such fields are small and usually know each other well. So, they tend to find work of colleagues online even if published in journals with IF of 3 or 4. As journals with high IF are in “great demand,” their review process is time consuming and ultimately most of thework submitted does not get accepted. In the process, our data may become redundant in today’s exponentially progressive research environment. Can we afford to face this? The final stumbling block is that if such journals are open access, they command a high premium in terms of publication “processing fees.” For instance, last year, Nature announced a princely sum of Euro 9,500 as their charges if the authors wanted their article to have open access. Clearly, this is an elitist attitudewhere rich publishing houseswant to get richer at the cost of dissemination of information. This has a major health care implication.Work from lowandmediumincome countries (LMIC) will not be published in such journals. Or the work will be behind a paywall that the LMIC colleagues cannot surmount.5 No wonder global citation inequality is increasing. Data between 2000 and 2015 encompassing 1million authors and 26million scientific publications show interesting confirmation of the same.6 Citations have increased from 14 to 21% only for the tip 1% of most cited researchers. The increasing trend was most prominent in the Netherland, Denmark, Australia, and United Kingdom. Interestingly, it showed a decline in the United States and China. IF has actually become so frustrating and misleading that many grant providers have started ignoring any reference to Purvish M. Parikh","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2023-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Technology and Innovation Has Made Impact Factor Redundant—Better Alternatives Are Here to Thrive\",\"authors\":\"Purvish M. Parikh, A. Vora\",\"doi\":\"10.1055/s-0043-1767699\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Three recent publications have let the cat out of the bag. They are “Stop Congratulating Colleagues for Publishing in High Impact-Factor Journals,” “Who are the real parasite publishers and journals? What prevents all medical data from being open access in real time?” and “Against Parasite Publishers: Making Journals Free.”1–3 For long impact factor (IF) has ruled the academic publishing world. It has expanded its sphere of influence on career progress, appointments in academic institutions, promotion reviews, and grant applications. IF is popular since 1975 and is based on the number of citations that the journal received in the previous 2 years. For instance, if our article is published in the year 2022, the IF that the journal in which our article is published will be decided on the citations received by the journal in the years 2020 and 2021. Authors are cognizant of the significance of IF because journals with higher IF are considered as respectable, their review process is supposed to be selective, there is greater scrutiny of articles submitted, and if published, the authors are considered worthy by their peers. Publications in journals with high IF also cascade into wider publicity through reporting by science journals and social media. They also have a higher chance of being included in reports on new publications. As the definition suggests, there is also a higher chance of being cited by other scientists working in the field. However, IF has a very important flaw. All the metrics are related to the journal. There is no evaluation of the individual publication or the author who has done the research work. Therefore, having a publication in a high IF journal does not guarantee that your work will be cited. In fact, more than two-thirds of publications in such journals have fewer citations than the IF of the journal.4 By experience, we have found that using the right keywords does wonders to online access. When the research work is great, those interested in the subject can easily find it on the net. Searchable databases such as Scopus, Google Scholar, and Web of Science make this possible. There are also niche areas in science andmedicine, where journals with high IF simply do not exist. The research communities in such fields are small and usually know each other well. So, they tend to find work of colleagues online even if published in journals with IF of 3 or 4. As journals with high IF are in “great demand,” their review process is time consuming and ultimately most of thework submitted does not get accepted. In the process, our data may become redundant in today’s exponentially progressive research environment. Can we afford to face this? The final stumbling block is that if such journals are open access, they command a high premium in terms of publication “processing fees.” For instance, last year, Nature announced a princely sum of Euro 9,500 as their charges if the authors wanted their article to have open access. Clearly, this is an elitist attitudewhere rich publishing houseswant to get richer at the cost of dissemination of information. This has a major health care implication.Work from lowandmediumincome countries (LMIC) will not be published in such journals. Or the work will be behind a paywall that the LMIC colleagues cannot surmount.5 No wonder global citation inequality is increasing. Data between 2000 and 2015 encompassing 1million authors and 26million scientific publications show interesting confirmation of the same.6 Citations have increased from 14 to 21% only for the tip 1% of most cited researchers. The increasing trend was most prominent in the Netherland, Denmark, Australia, and United Kingdom. Interestingly, it showed a decline in the United States and China. IF has actually become so frustrating and misleading that many grant providers have started ignoring any reference to Purvish M. Parikh\",\"PeriodicalId\":22053,\"journal\":{\"name\":\"South Asian Journal of Cancer\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2023-04-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"South Asian Journal of Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0043-1767699\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"South Asian Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1767699","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

最近的三份出版物泄露了秘密。它们是“停止祝贺同事在高影响因子期刊上发表”、“谁是真正的寄生虫出版商和期刊?是什么阻止了所有医疗数据的实时开放?”和“反对寄生虫出版商:让期刊免费。”1-3长期影响因子(IF)统治着学术出版界。它扩大了对职业发展、学术机构任命、晋升审查和拨款申请的影响范围。《IF》自1975年以来就很受欢迎,它是基于该杂志在过去两年中收到的引用次数。例如,如果我们的文章在2022年发表,我们文章发表的期刊的if将根据该期刊在2020年和2021年收到的引文来决定。作者认识到IF的重要性,因为IF较高的期刊被认为是受人尊敬的,他们的审查过程应该是有选择性的,对提交的文章有更严格的审查,如果发表,作者被同行认为是有价值的。通过科学期刊和社交媒体的报道,IF高的期刊上的出版物也会引起更广泛的宣传。它们也有更高的机会被纳入关于新出版物的报告。正如定义所示,被该领域的其他科学家引用的几率也更高。然而,IF有一个非常重要的缺陷。所有指标都与日志相关。没有对个人出版物或从事研究工作的作者进行评估。因此,在高IF期刊上发表文章并不能保证你的作品会被引用。事实上,这类期刊上超过三分之二的出版物的引用次数少于该期刊的IF。4根据经验,我们发现使用正确的关键词对在线访问有很大帮助。当研究工作很出色时,那些对这门学科感兴趣的人可以很容易地在网上找到它。Scopus、Google Scholar和Web of Science等可搜索数据库使这成为可能。在科学和医学领域也有一些小众领域,根本不存在具有高IF的期刊。这类领域的研究团体规模较小,通常彼此都很了解。因此,即使在if为3或4的期刊上发表,他们也倾向于在网上找到同事的作品。由于IF高的期刊“需求量很大”,它们的评审过程很耗时,最终提交的大部分作品都没有被接受。在这个过程中,在当今指数级进步的研究环境中,我们的数据可能会变得多余。我们能承受得起吗?最后的障碍是,如果这些期刊是开放获取的,它们在出版“处理费”方面会获得很高的溢价。例如,去年,《自然》杂志宣布,如果作者希望他们的文章能够开放获取,他们将收取9500欧元的巨额费用。显然,这是一种精英主义的态度——富有的出版社以传播信息为代价变得更富有。这对医疗保健有重大影响。来自中低收入国家(LMIC)的作品将不会在此类期刊上发表。或者,这项工作将是LMIC同事无法逾越的付费墙。5难怪全球引文不平等现象正在加剧。2000年至2015年间的数据涵盖了100万作者和2600万份科学出版物,这一数据令人感兴趣地证实了这一点。6被引用最多的研究人员中,只有1%的人的引用率从14%增加到21%。增长趋势在荷兰、丹麦、澳大利亚和英国最为突出。有趣的是,它在美国和中国都有所下降。事实上,国际单项体育联合会已经变得如此令人沮丧和误导,以至于许多赠款提供者开始忽视任何对Purvish M.Parikh的提及
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Technology and Innovation Has Made Impact Factor Redundant—Better Alternatives Are Here to Thrive
Three recent publications have let the cat out of the bag. They are “Stop Congratulating Colleagues for Publishing in High Impact-Factor Journals,” “Who are the real parasite publishers and journals? What prevents all medical data from being open access in real time?” and “Against Parasite Publishers: Making Journals Free.”1–3 For long impact factor (IF) has ruled the academic publishing world. It has expanded its sphere of influence on career progress, appointments in academic institutions, promotion reviews, and grant applications. IF is popular since 1975 and is based on the number of citations that the journal received in the previous 2 years. For instance, if our article is published in the year 2022, the IF that the journal in which our article is published will be decided on the citations received by the journal in the years 2020 and 2021. Authors are cognizant of the significance of IF because journals with higher IF are considered as respectable, their review process is supposed to be selective, there is greater scrutiny of articles submitted, and if published, the authors are considered worthy by their peers. Publications in journals with high IF also cascade into wider publicity through reporting by science journals and social media. They also have a higher chance of being included in reports on new publications. As the definition suggests, there is also a higher chance of being cited by other scientists working in the field. However, IF has a very important flaw. All the metrics are related to the journal. There is no evaluation of the individual publication or the author who has done the research work. Therefore, having a publication in a high IF journal does not guarantee that your work will be cited. In fact, more than two-thirds of publications in such journals have fewer citations than the IF of the journal.4 By experience, we have found that using the right keywords does wonders to online access. When the research work is great, those interested in the subject can easily find it on the net. Searchable databases such as Scopus, Google Scholar, and Web of Science make this possible. There are also niche areas in science andmedicine, where journals with high IF simply do not exist. The research communities in such fields are small and usually know each other well. So, they tend to find work of colleagues online even if published in journals with IF of 3 or 4. As journals with high IF are in “great demand,” their review process is time consuming and ultimately most of thework submitted does not get accepted. In the process, our data may become redundant in today’s exponentially progressive research environment. Can we afford to face this? The final stumbling block is that if such journals are open access, they command a high premium in terms of publication “processing fees.” For instance, last year, Nature announced a princely sum of Euro 9,500 as their charges if the authors wanted their article to have open access. Clearly, this is an elitist attitudewhere rich publishing houseswant to get richer at the cost of dissemination of information. This has a major health care implication.Work from lowandmediumincome countries (LMIC) will not be published in such journals. Or the work will be behind a paywall that the LMIC colleagues cannot surmount.5 No wonder global citation inequality is increasing. Data between 2000 and 2015 encompassing 1million authors and 26million scientific publications show interesting confirmation of the same.6 Citations have increased from 14 to 21% only for the tip 1% of most cited researchers. The increasing trend was most prominent in the Netherland, Denmark, Australia, and United Kingdom. Interestingly, it showed a decline in the United States and China. IF has actually become so frustrating and misleading that many grant providers have started ignoring any reference to Purvish M. Parikh
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
80
审稿时长
35 weeks
期刊最新文献
Staging and Management of Cervical Cancer at the Colposcopy Clinic of Bangabandhu Sheikh Sheikh Mujib Medical University (BSMMU), Bangladesh. COVID-19 Impact on Newly Diagnosed Breast Cancers at Regional Cancer Centre, Thiruvananthapuram-An Audit. Do Uro-Oncology Day Care Procedures Need to Be Differed during COVID-19 Pandemic?-An Experience from Tertiary Cancer Care Center. Colorectal Origin: A Marker of Favorable Outcome in Krukenberg Tumor? Results from Clinical and Prognostic Analysis. Cytogenetic Alterations and Correlation with Age and Gender in Patients of Multiple Myeloma: A Study from a Tertiary Care Center in Eastern India.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1